Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection

Leukemia. 2020 May;34(5):1462-1466. doi: 10.1038/s41375-019-0687-2. Epub 2019 Dec 13.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antiviral Agents / therapeutic use*
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / pathology
  • Female
  • Follow-Up Studies
  • Hepacivirus / drug effects
  • Hepacivirus / isolation & purification*
  • Hepatitis C / complications*
  • Hepatitis C / virology
  • Humans
  • Interferon-alpha / therapeutic use*
  • Lymphoproliferative Disorders / drug therapy
  • Lymphoproliferative Disorders / mortality*
  • Lymphoproliferative Disorders / virology
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Survival Rate
  • Young Adult

Substances

  • Antiviral Agents
  • Interferon-alpha